GCM
INBX icon

Graham Capital Management’s Inhibrx INBX Stock Holding History

Graham Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$352K Buy
+5,242
New +$389K 0.01% 752

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Graham Capital Management's INBX Position: Q1 2026 in Review

Graham Capital Management opened a new position in Inhibrx (INBX) in Q1 2026: 5,242 shares worth $352K. The stake represents 0.01% of the portfolio and ranks #752 among its holdings.

135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Graham Capital Management held 5,242 shares of Inhibrx worth $352K as of Q1 2026.
  • Inhibrx was a new Graham Capital Management position in Q1 2026.
  • Inhibrx made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #752 holding.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.